Dr Michael Antoniou's Group
Head: Dr Michael Antoniou
Degrees: Biochemistry, BA (Oxon), University of Oxford (Hertford College), 1973-1977. Ph.D, University of Reading, 1977-1980.
Current members of the Gene Expression & Therapy Group (GETG)
Post-doctoral scientist: Dr Robin Mesnage
Graduate research assistant: Alexia Phedonos
PhD students: Christina Flouri; Bethany McCloskey
Group research interests
We are a small group but with a diverse range of interests employing cell and molecular analytical approaches to investigate transcriptional and post-transcriptional events that regulate gene expression including in response to various environmental stimuli.
Historically the main research focus of the GETG is the characterisation of genetic regulatory elements with a dominant chromatin remodelling (opening) capability and their exploitation in the development of efficient expression vectors for efficacious and safe biotechnological applications namely protein therapeutic biomanufacturing and human gene therapy.
Recently the GETG has expanded its research work into a new area where molecular profiling (“omics”) tools are employed to investigate the endocrine disruptive capability of low, environmentally relevant doses of key pesticides and other chemical pollutants.